• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by Cadre Holdings Inc.

    3/14/25 4:29:48 PM ET
    $CDRE
    Industrial Specialties
    Health Care
    Get the next $CDRE alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0000935577
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    Cadre Holdings, Inc.
    SEC File Number
    001-40698
    Address of Issuer
    13386 INTERNATIONAL PKWY
    JACKSONVILLE
    FLORIDA
    32218
    Phone
    (904) 741-5400
    Name of Person for Whose Account the Securities are To Be Sold
    KANDERS WARREN B
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Officer
    Relationship to Issuer
    Director
    Relationship to Issuer
    10% Stockholder

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Common
    Merrill Lynch
    225 Liberty St
    39th Floor
    New York � NY � 10281
    75000025395000.004060798803/14/2025
    NYSE


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Common12/07/2021Liquidating distribution based upon the reporting person's pro rata membership interest in Maui Holdings LLCMaui Holdings LLCCheckbox not checked1586670312/07/2021Stock

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Name and Address of SellerTitle of Securities SoldDate of SaleAmount of Securities SoldGross Proceeds
    Kanders SAF LLC
    340 Royal Poinciana Way
    Ste 317-250
    Palm Beach � FL � 33480-8001
    Common12/16/202412133441400.00

    144: Remarks and Signature

    Remarks
    Locking in four-week average for week ending 03/07/25 for 800,698 shares
    Date of Notice
    03/14/2025

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    Warren B. Kanders

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $CDRE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CDRE

    DatePrice TargetRatingAnalyst
    2/21/2024$32.00 → $38.00Buy
    ROTH MKM
    1/22/2024Outperform → Mkt Perform
    Raymond James
    9/6/2022$30.00Buy
    BofA Securities
    8/31/2022$32.00Buy
    Jefferies
    3/11/2022$25.00 → $27.00Outperform
    Raymond James
    11/29/2021$24.00Buy
    Lake Street
    11/29/2021$23.00Overweight
    Stephens
    11/29/2021$20.00Hold
    Stifel
    More analyst ratings

    $CDRE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Cadre Holdings Reports First Quarter 2025 Financial Results

      Capitalizes on Continued Strong Demand for Mission Critical Safety Equipment Completes Acquisition of Multiple Leading Nuclear Brands, Expanding Geographic Footprint Increased Guidance Reflects Completed Acquisition and Reaffirmed Organic Growth Expectations 2025 Outlook: Net Sales of $618 to $648 Million and Adjusted EBITDA of $112 to $122 Million Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the three months ended March 31, 2025. Net sales of $130.

      5/6/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Announces First Quarter 2025 Earnings and Conference Call Information

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that it plans to release financial results for the first quarter that ended on March 31, 2025, on Tuesday, May 6, 2025, after the close of market trading. The company has scheduled a conference call to discuss these results on Wednesday, May 7, 2025, at 10:00 a.m. ET. The conference call will feature remarks by Warren Kanders, CEO and Chairman of the Board; Brad Williams, President; and Blaine Browers, Chief Financial Officer. To participate in

      4/23/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Declares Quarterly Dividend of $0.095 Per Share

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that its Board of Directors has declared a quarterly cash dividend of $0.095 per share, or $0.38 per share on an annualized basis. Cadre's dividend payment will be made on May 16, 2025 to shareholders of record as of the close of business on the record date of May 2, 2025. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors. About Cadre Headquartered in Jacksonville, Florida, Cadre is a globa

      4/22/25 4:16:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    SEC Filings

    See more
    • SEC Form 10-Q filed by Cadre Holdings Inc.

      10-Q - Cadre Holdings, Inc. (0001860543) (Filer)

      5/6/25 4:17:42 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Cadre Holdings, Inc. (0001860543) (Filer)

      5/6/25 4:15:16 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by Cadre Holdings Inc.

      SCHEDULE 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

      4/29/25 4:15:29 PM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    Leadership Updates

    Live Leadership Updates

    See more
    • Cadre Holdings Appoints Gianmaria Delzanno to its Board of Directors

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced the appointment of Gianmaria Delzanno to its board of directors, effective as of January 13, 2025. Current Director Nicholas Sokolow, who joined the board of Cadre's predecessor in July of 2012, will retire from the Company's board, effective as of January 31, 2025. Upon Mr. Sokolow's departure, Mr. Delzanno will replace Mr. Sokolow as the lead independent director and will also serve as Chairman of the Nominating and Corporate Governance Committee as

      1/13/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Appoints Deborah DeCotis to its Board of Directors

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety and survivability equipment for first responders, announced the appointment of Deborah DeCotis to its board of directors, effective immediately. With Ms. DeCotis' appointment, the Board will expand to five directors, four of whom are independent. Ms. DeCotis will also serve on the Company's Compensation Committee. Ms. DeCotis has over 45 years of financial, advisory and business operations experience with a successful track record of leadership across multiple global institutions and industries. She currently serves as Advisory Director at Morgan Stanley & Co., Inc.

      4/12/22 8:30:00 AM ET
      $CDRE
      Industrial Specialties
      Health Care
    • ElectraMeccanica Appoints Automotive Veteran, William Quigley III, to Board of Directors

      VANCOUVER, British Columbia, April 07, 2022 (GLOBE NEWSWIRE) -- ElectraMeccanica Vehicles Corp. (NASDAQ:SOLO) ("ElectraMeccanica" or the "Company"), a designer and manufacturer of electric vehicles revolutionizing the urban driving experience, today announced the appointment of William (Bill) Quigley III to its Board of Directors. Mr. Quigley is an accomplished leader with a proven track record in large enterprises specific to the automotive industry. With 30 plus years in the industry, Bill's career has included the following key roles: Executive Vice President and Chief Financial Officer at Dana Holding Corporation, an automotive, commercial vehicle and off-highway driveline, sealing an

      4/7/22 8:05:00 AM ET
      $CDRE
      $SOLO
      Industrial Specialties
      Health Care
      Auto Manufacturing
      Consumer Discretionary

    $CDRE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • ROTH MKM reiterated coverage on Cadre Holdings with a new price target

      ROTH MKM reiterated coverage of Cadre Holdings with a rating of Buy and set a new price target of $38.00 from $32.00 previously

      2/21/24 9:51:23 AM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings downgraded by Raymond James

      Raymond James downgraded Cadre Holdings from Outperform to Mkt Perform

      1/22/24 7:15:32 AM ET
      $CDRE
      Industrial Specialties
      Health Care
    • BofA Securities initiated coverage on Cadre Holdings with a new price target

      BofA Securities initiated coverage of Cadre Holdings with a rating of Buy and set a new price target of $30.00

      9/6/22 7:24:20 AM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    Financials

    Live finance-specific insights

    See more
    • Cadre Holdings Reports First Quarter 2025 Financial Results

      Capitalizes on Continued Strong Demand for Mission Critical Safety Equipment Completes Acquisition of Multiple Leading Nuclear Brands, Expanding Geographic Footprint Increased Guidance Reflects Completed Acquisition and Reaffirmed Organic Growth Expectations 2025 Outlook: Net Sales of $618 to $648 Million and Adjusted EBITDA of $112 to $122 Million Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the three months ended March 31, 2025. Net sales of $130.

      5/6/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Announces First Quarter 2025 Earnings and Conference Call Information

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that it plans to release financial results for the first quarter that ended on March 31, 2025, on Tuesday, May 6, 2025, after the close of market trading. The company has scheduled a conference call to discuss these results on Wednesday, May 7, 2025, at 10:00 a.m. ET. The conference call will feature remarks by Warren Kanders, CEO and Chairman of the Board; Brad Williams, President; and Blaine Browers, Chief Financial Officer. To participate in

      4/23/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Declares Quarterly Dividend of $0.095 Per Share

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that its Board of Directors has declared a quarterly cash dividend of $0.095 per share, or $0.38 per share on an annualized basis. Cadre's dividend payment will be made on May 16, 2025 to shareholders of record as of the close of business on the record date of May 2, 2025. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors. About Cadre Headquartered in Jacksonville, Florida, Cadre is a globa

      4/22/25 4:16:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: SEC Form 4 filed by CHIEF FINANCIAL OFFICER Browers Blaine

      4/A - Cadre Holdings, Inc. (0001860543) (Issuer)

      4/24/25 4:47:07 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Amendment: SEC Form 4 filed by PRESIDENT Williams Brad

      4/A - Cadre Holdings, Inc. (0001860543) (Issuer)

      4/24/25 4:45:45 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Amendment: SEC Form 4 filed by CEO AND CHAIRMAN Kanders Warren B

      4/A - Cadre Holdings, Inc. (0001860543) (Issuer)

      4/24/25 4:45:13 PM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Cadre Holdings Inc.

      SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

      11/12/24 9:50:14 AM ET
      $CDRE
      Industrial Specialties
      Health Care
    • SEC Form SC 13G filed by Cadre Holdings Inc.

      SC 13G - Cadre Holdings, Inc. (0001860543) (Subject)

      2/14/24 7:58:49 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • SEC Form SC 13G/A filed by Cadre Holdings Inc. (Amendment)

      SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

      2/12/24 4:15:31 PM ET
      $CDRE
      Industrial Specialties
      Health Care